$17.82
1.87% day before yesterday
NYSE, Nov 01, 09:00 pm CET
ISIN
US1638511089
Symbol
CC

Chemours Co. Stock price

$17.82
-1.89 9.59% 1M
-8.18 31.46% 6M
-13.72 43.50% YTD
-6.12 25.56% 1Y
-10.89 37.93% 3Y
+0.46 2.65% 5Y
-3.03 14.53% 10Y
NYSE, Closing price Fri, Nov 01 2024
-0.34 1.87%
ISIN
US1638511089
Symbol
CC

Key metrics

Market capitalization $2.66b
Enterprise Value $6.28b
P/E (TTM) P/E ratio 23.11
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.09
P/S ratio (TTM) P/S ratio 0.46
P/B ratio (TTM) P/B ratio 3.68
Dividend yield 5.61%
Last dividend (FY24) $1.00
Revenue growth (TTM) Revenue growth -8.87%
Revenue (TTM) Revenue $5.74b
EBIT (operating result TTM) EBIT $343.00m
Free Cash Flow (TTM) Free Cash Flow $-692.00m
Cash position $619.00m
EPS (TTM) EPS $0.77
P/E forward 14.28
P/S forward 0.47
EV/Sales forward 1.10
Short interest 7.99%
Show more

Is Chemours Co. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Chemours Co. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Chemours Co. forecast:

5x Buy
42%
6x Hold
50%
1x Sell
8%

Analyst Opinions

12 Analysts have issued a Chemours Co. forecast:

Buy
42%
Hold
50%
Sell
8%

Financial data from Chemours Co.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
5,736 5,736
9% 9%
100%
- Direct Costs 4,616 4,616
5% 5%
80%
1,120 1,120
22% 22%
20%
- Selling and Administrative Expenses 374 374
59% 59%
7%
- Research and Development Expense 108 108
7% 7%
2%
638 638
60% 60%
11%
- Depreciation and Amortization 295 295
3% 3%
5%
EBIT (Operating Income) EBIT 343 343
257% 257%
6%
Net Profit 116 116
232% 232%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Chemours Co. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Chemours Co. Stock News

Neutral
Business Wire
11 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.
Negative
Seeking Alpha
13 days ago
Wolfspeed rallied due to a $750 million investment from Apollo Global Management, despite high short interest and bearish sentiment. SolarEdge Technologies faces significant competition and high inventory levels, making it a potential tax-loss selling candidate. Moderna's stock is under pressure due to declining Covid-19 vaccine demand and weakened profitability, suggesting it should be sold.
Neutral
Business Wire
20 days ago
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2024 Earnings Release and Webcast Conference Call.
More Chemours Co. News

Company Profile

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.

Head office United States
CEO Denise Dignam
Employees 6,200
Founded 2014
Website www.chemours.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today